Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects

NCT05363293 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Healthy Non-elderly and Elderly Adults

Interventions

DRUG: AL001
OTHER: Placebo

Sponsor

Alzamend Neuro, Inc.